- Home
- ALLO vs CEPF Comparison
ALLO vs CEPF Comparison
Compare ALLO & CEPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.06
Company Overview
Basic Information| Metric | ALLO | CEPF |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 593.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALLO | CEPF |
|---|---|---|
| Price | $2.06 | $10.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 7.8M | 54.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | $96.45 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $10.09 |
| 52 Week High | $4.46 | $10.67 |
Technical Indicators
Market Signals| Indicator | ALLO | CEPF |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 53.53 |
| Support Level | $1.85 | $10.33 |
| Resistance Level | $2.36 | $10.35 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 74.12 | 76.47 |
Price Performance
Historical Comparison ALLO
CEPF
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About CEPF Cantor Equity Partners IV Inc. Class A Ordinary Shares
Cantor Equity Partners IV Inc is a blank check company.